Get started
NNN

NEURIZON THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

NUZ chart


Full chart

Key stats


Market capitalization
‪93.42 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.020 AUD
Net income (FY)
‪−9.03 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪350.53 M‬
Beta (1Y)
0.42

About NEURIZON THERAPEUTICS LIMITED


Sector
Health Technology
CEO
Michael Thurn
Headquarters
South Melbourne
Website
pharmaust.com
Founded
2000
ISIN
AU0000357261
FIGI
BBG000BTR7D4
Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research, and Pharmaceutical-Epichem segments. The Corporate and Research segment includes corporate overhead expenses. The Pharmaceutical-Epichem segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company was founded on December 2003 and is headquartered in Claremont, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NUZ news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NUZ is 0.200 AUD — it hasn't changed in the past 24 hours. Watch NEURIZON THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NEURIZON THERAPEUTICS LIMITED stocks are traded under the ticker NUZ.
NUZ stock has fallen by −7.32% compared to the previous week, the month change is a −15.56% fall, over the last year NEURIZON THERAPEUTICS LIMITED has showed a 132.56% increase.
We've gathered analysts' opinions on NEURIZON THERAPEUTICS LIMITED future price: according to them, NUZ price has a max estimate of 0.42 AUD and a min estimate of 0.42 AUD. Watch NUZ chart and read a more detailed NEURIZON THERAPEUTICS LIMITED stock forecast: see what analysts think of NEURIZON THERAPEUTICS LIMITED and suggest that you do with its stocks.
NUZ reached its all-time high on Feb 28, 2024 with the price of 0.535 AUD, and its all-time low was 0.030 AUD and was reached on Aug 17, 2018. View more price dynamics on NUZ chart.
See other stocks reaching their highest and lowest prices.
NUZ stock is 7.69% volatile and has beta coefficient of 0.42. Track NEURIZON THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is NEURIZON THERAPEUTICS LIMITED there?
Yes, you can track NEURIZON THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
NUZ net income for the last half-year is ‪−7.30 M‬ AUD, while the previous report showed ‪−389.24 K‬ AUD of net income which accounts for ‪−1.77 K‬% change. Track more NEURIZON THERAPEUTICS LIMITED financial stats to get the full picture.
No, NUZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NUZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEURIZON THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEURIZON THERAPEUTICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEURIZON THERAPEUTICS LIMITED stock shows the buy signal. See more of NEURIZON THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.